DVA: DaVita Inc. Stock

by  •  • Comments Off on DVA: DaVita Inc. Stock

SIC 809 – Miscellaneous Health And Allied Services, Not

Valuation
Market Cap ($M) 12,497.62
Enterprise Value ($M) 22,990.69
Book Value ($M) 2,635.99
Book Value / Share 30.06
Price / Book 4.74
NCAV ($M) -11,111.19
NCAV / Share -126.69
Price / NCAV -1.12

Profitability (mra)
Return on Invested Capital (ROIC) 0.06
Return on Assets (ROA) 0.05
Return on Equity (ROE) 0.31

Liquidity (mrq)
Quick Ratio 1.37
Current Ratio 1.43

Balance Sheet (mrq) ($M)
Current Assets 3,683.75
Assets 17,430.94
Liabilities 14,794.95
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 12,140.15
Operating Income 1,701.00
Net Income 691.53
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 2,059.03
Cash from Investing -771.80
Cash from Financing -1,170.49

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-16 13D/A Berkshire Hathaway Inc 41.20 0.00
02-13 13G/A Vanguard Group Inc 6.92 2.51
01-31 13G/A BlackRock Inc. 5.20 -0.66

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO
2024-02-14 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTI
2023-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT
2023-08-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO S

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-07-26 279,750 729,537 38.35
2024-07-25 70,411 241,777 29.12
2024-07-24 73,682 281,849 26.14
2024-07-23 67,314 263,959 25.50
2024-07-22 57,583 313,922 18.34

(click for more detail)

Similar Companies
AGL – agilon health, inc.


Financial data and stock pages provided by
Fintel.io